High-Cost Generic Drugs — Implications for Patients and Policymakers
Full Text Reports... 2014-11-19
High-Cost Generic Drugs — Implications for Patients and Policymakers Source: New England Journal of Medicine It is well known that new brand-name drugs are often expensive, but U.S. health care is also witnessing a lesser-known but growing and seemingly paradoxical phenomenon: certain older drugs, many of which are generic and not protected by patents or […]
From feeds:Berkeley -- Test » Full Text Reports...
BerkeleyTest » Full Text Reports...